The promising procognitive effects seen with GH and IGF-1 treatment, as well as the neuroprotective properties, suggest that GH and IGF-1 may be effective pharmacological interventions for opioid-induced cognitive impairment. This evidence concerns the gene GH1 and Cognitive impairment.